MedPath

Carboprost Tromethamine

Carboprost Tromethamine Injection, USP Package Insert

Approved
Approval ID

f0b2d3f9-859a-47bb-866c-082717d1f190

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 19, 2022

Manufacturers
FDA

Long Grove Pharmaceuticals, LLC

DUNS: 081134465

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carboprost Tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code81298-5010
Application NumberANDA214499
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carboprost Tromethamine
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateOctober 19, 2022
FDA Product Classification

INGREDIENTS (6)

Carboprost TromethamineActive
Quantity: 250 ug in 1 mL
Code: U4526F86FJ
Classification: ACTIM
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
Benzyl AlcoholInactive
Code: LKG8494WBH
Classification: IACT
Sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
Sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
TromethamineInactive
Code: 023C2WHX2V
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carboprost Tromethamine - FDA Drug Approval Details